2019-2021 ASH Clinical Practice Guidelines on Sickle Cell Disease: What You Should Know

The American Society of Hematology (ASH) believes it is essential to provide updated treatment guidelines that reflect the newest evidence about the disease, ensuring the medical community can better treat SCD and people living with SCD can make the best decisions for their care. In partnership with the Evidence-Based Practice Research Program at Mayo Clinic, the 2019-2021 ASH Clinical Practice Guidelines on Sickle Cell Disease (SCD) were developed using the GRADE methodology to ensure the highest standards for trustworthiness. ASH brought together more than 70 experts, including hematologists, clinicians from other specialties, and patient and caregiver representatives to identify best practices for the management of acute and chronic complications of SCD and ways to improve the quality of care for people living with SCD.   Abstract source